Jennifer L Barton1, Simon Décary2,3. 1. Oregon Health & Science University, VA Portland Healthcare System, Portland, Oregon, USA. 2. Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation, Centre de recherche sur les soins et les services de première ligne de l'Université Laval (CERSSPL-UL). 3. Department of Family Medicine and Emergency Medicine, Université Laval, Quebec, Canada.
Abstract
PURPOSE OF REVIEW: Implementing shared decision-making (SDM) is a top international priority to improve care for persons living with rheumatoid arthritis. Using SDM tools, such as decision aids improve patients' knowledge and support communication with their clinicians on treatment benefits and risks. Despite calls for SDM in treat-to-target, studies demonstrating effective SDM strategies in rheumatology clinical practice are scarce. Our objective was to identify recent and relevant literature on SDM in rheumatoid arthritis. RECENT FINDINGS: We found a burgeoning literature on SDM in rheumatoid arthritis that tackles issues of implementation. Studies have evaluated the SDM process within clinical consultations and found that uptake is suboptimal. Trials of newly developed patient decision aids follow high methodological standards, but large-scale implementation is lacking. Innovative SDM strategies, such as shared goals and preference phenotypes may improve implementation of treat-to-target approach. Research and patient engagement are standardizing measures of SDM for clinical uses. SUMMARY: Uptake of SDM in rheumatoid arthritis holds promise in wider clinicians' and patients' awareness, availability of decision aids, and broader treat-to-target implementation strategies, such as the learning collaborative. Focused attention is needed on facilitating SDM among diverse populations and those at risk of poorer outcomes and barriers to communication.
PURPOSE OF REVIEW: Implementing shared decision-making (SDM) is a top international priority to improve care for persons living with rheumatoid arthritis. Using SDM tools, such as decision aids improve patients' knowledge and support communication with their clinicians on treatment benefits and risks. Despite calls for SDM in treat-to-target, studies demonstrating effective SDM strategies in rheumatology clinical practice are scarce. Our objective was to identify recent and relevant literature on SDM in rheumatoid arthritis. RECENT FINDINGS: We found a burgeoning literature on SDM in rheumatoid arthritis that tackles issues of implementation. Studies have evaluated the SDM process within clinical consultations and found that uptake is suboptimal. Trials of newly developed patient decision aids follow high methodological standards, but large-scale implementation is lacking. Innovative SDM strategies, such as shared goals and preference phenotypes may improve implementation of treat-to-target approach. Research and patient engagement are standardizing measures of SDM for clinical uses. SUMMARY: Uptake of SDM in rheumatoid arthritis holds promise in wider clinicians' and patients' awareness, availability of decision aids, and broader treat-to-target implementation strategies, such as the learning collaborative. Focused attention is needed on facilitating SDM among diverse populations and those at risk of poorer outcomes and barriers to communication.
Authors: Betty Hsiao; Pauline Binder-Finnema; W Benjamin Nowell; George Michel; Carole Wiedmeyer; Liana Fraenkel Journal: Arthritis Care Res (Hoboken) Date: 2019-04-08 Impact factor: 4.794
Authors: Fania R Gärtner; Hanna Bomhof-Roordink; Ian P Smith; Isabelle Scholl; Anne M Stiggelbout; Arwen H Pieterse Journal: PLoS One Date: 2018-02-15 Impact factor: 3.240
Authors: France Légaré; Michel Labrecque; Michel Cauchon; Josette Castel; Stéphane Turcotte; Jeremy Grimshaw Journal: CMAJ Date: 2012-07-30 Impact factor: 8.262
Authors: Jennifer L Barton; Christopher J Koenig; Gina Evans-Young; Laura Trupin; Jennie Anderson; Dana Ragouzeos; Maggie Breslin; Timothy Morse; Dean Schillinger; Victor M Montori; Edward H Yelin Journal: BMC Med Inform Decis Mak Date: 2014-11-25 Impact factor: 2.796
Authors: Natalie Joseph-Williams; Robert Newcombe; Mary Politi; Marie-Anne Durand; Stephanie Sivell; Dawn Stacey; Annette O'Connor; Robert J Volk; Adrian Edwards; Carol Bennett; Michael Pignone; Richard Thomson; Glyn Elwyn Journal: Med Decis Making Date: 2013-08-20 Impact factor: 2.583
Authors: Karen R Sepucha; Purva Abhyankar; Aubri S Hoffman; Hilary L Bekker; Annie LeBlanc; Carrie A Levin; Mary Ropka; Victoria A Shaffer; Stacey L Sheridan; Dawn Stacey; Peep Stalmeier; Ha Vo; Celia E Wills; Richard Thomson Journal: BMJ Qual Saf Date: 2017-12-21 Impact factor: 7.418
Authors: Glyn Elwyn; Marie Anne Durand; Julia Song; Johanna Aarts; Paul J Barr; Zackary Berger; Nan Cochran; Dominick Frosch; Dariusz Galasiński; Pål Gulbrandsen; Paul K J Han; Martin Härter; Paul Kinnersley; Amy Lloyd; Manish Mishra; Lilisbeth Perestelo-Perez; Isabelle Scholl; Kounosuke Tomori; Lyndal Trevena; Holly O Witteman; Trudy Van der Weijden Journal: BMJ Date: 2017-11-06
Authors: Karin Schölin Bywall; Jennifer Viberg Johansson; Inger Erlandsson; Marie Heidenvall; Marta Lason; Bente Appel Esbensen Journal: BMJ Open Date: 2022-06-01 Impact factor: 3.006